肿瘤细胞治疗研究
ALL SOURCES
Immune microenvironment features underlying the superior efficacy of neoadjuvant immunochemotherapy over chemotherapy in local advanced gastric cancer
我们的研究支持新辅助 Io+Chemo 优于 Chemo，并揭示 Io+Chemo 可诱导形成免疫激活的微环境，从而使 Io+Chemo 优于 Chemo。
Tumor-infiltrating immune cell profiles and changes associate with additional trastuzumab in preoperative chemotherapy for patients with HER2-positive
曲妥珠单抗的加入调节了免疫微环境，提示了抗HER2治疗良好结局的潜在机制，并为可切除HER2(+) GC患者的联合免疫治疗提供了理论依据。
Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
CLDN18.2阳性GC显示出独特的免疫微环境特征，这对CLDN18.2靶向治疗的开发具有重要意义。然而，CLDN18.2相关微环境特征对预后的影响仍需进一步研究。
CD2AP shapes a stromal reduced tumor microenvironment and contributes to immunotherapy in gastric cancer.
胃癌（GC）是全球第五大常见恶性肿瘤，也是第四大癌症相关死亡原因。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
